T. Rowe Price Investment Management, Inc.
Position in ASND — Ascendis Pharma A/S
CIK 1897612
BALTIMORE, MD
Position in ASND
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,801,652,525
+$392,208,659 QoQ
Shares Held
6,754,846
+9.6% QoQ
Ownership
10.3%
of shares outstanding
% of Portfolio
1.18%
of 13F equity value
Holder Rank
#2
of 308 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026T. Rowe Price Investment Management, Inc. holds $12,244,164,567 across 51 Biotechnology names. ASND ranks #1 (14.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
This page
|
6,754,846 | $1,801,652,525 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,642,173 | $1,698,463,338 | |
| 3 | CYTK |
Cytokinetics Inc
|
18,718,498 | $1,594,628,844 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
6,257,261 | $717,520,118 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
12,207,450 | $709,619,068 | |
| 6 | DYN |
Dyne Therapeutics, Inc.
|
30,912,287 | $686,561,894 | |
| 7 | CGON |
CG Oncology, Inc.
|
6,616,899 | $470,130,673 | |
| 8 | IMNM |
Immunome Inc.
|
19,676,883 | $416,953,150 |
All Filings in ASND
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,801,652,525 | 6,754,846 | Shares | Sole | 2026-08-14 | |
| 2026-04-30 | $1,492,396,514 | 6,506,219 | Shares | Sole | 2026-05-07 | |
| 2026-03-31 | $1,409,443,866 | 6,162,042 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $230,346,965 | 1,080,224 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $530,150,324 | 2,666,618 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $618,520,039 | 3,583,546 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $475,969,008 | 3,053,824 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $375,225,917 | 2,725,546 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $263,538,421 | 1,765,042 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,168,318 | 30,564 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $388,341,066 | 2,568,903 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $502,519,088 | 3,989,830 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $373,108,860 | 3,984,503 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $355,473,200 | 3,982,893 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $372,425,024 | 3,473,466 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $345,416,248 | 2,828,267 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $209,842,906 | 2,032,180 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||